Literature DB >> 8628291

A glycine-rich region in NF-kappaB p105 functions as a processing signal for the generation of the p50 subunit.

L Lin1, S Ghosh.   

Abstract

Transcription factor NF-kappaB is generally considered to be a heterodimer with two subunits, p50 and p65. The p50 subunit has been suggested to be generated from its precursor, p105, via the ubiquitin-proteasome pathway. During processing, the C-terminal portion of p105 is rapidly degraded whereas the N-terminal portion (p50) is left intact. We report here that a 23-amino-acid, glycine-rich region (GRR) in p105 functions as a processing signal for the generation of p50. A GRR-dependent endoproteolytic cleavage downstream of the GRR releases p50 from p105, and this cleavage does not require any specific downstream sequences. p50 can be generated from chimeric precursor p105N-GRR-IkappaBalpha, while the C-terminal portion (IkappaBalpha) can also be recovered, suggesting that p105 processing includes two steps: a GRR-dependent endoproteolytic cleavage and the subsequent degradation of the C-terminal portion. We have also demonstrated that the GRR can direct a similar processing event when it is inserted into a protein unrelated to the NF-kappaB family and that it is therefore an independent signal for processing.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8628291      PMCID: PMC231212          DOI: 10.1128/MCB.16.5.2248

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  Cloning of a mitogen-inducible gene encoding a kappa B DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs.

Authors:  V Bours; J Villalobos; P R Burd; K Kelly; U Siebenlist
Journal:  Nature       Date:  1990-11-01       Impact factor: 49.962

2.  Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal.

Authors:  S Ghosh; A M Gifford; L R Riviere; P Tempst; G P Nolan; D Baltimore
Journal:  Cell       Date:  1990-09-07       Impact factor: 41.582

3.  The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product.

Authors:  M Kieran; V Blank; F Logeat; J Vandekerckhove; F Lottspeich; O Le Bail; M B Urban; P Kourilsky; P A Baeuerle; A Israël
Journal:  Cell       Date:  1990-09-07       Impact factor: 41.582

4.  Use of T7 RNA polymerase to direct expression of cloned genes.

Authors:  F W Studier; A H Rosenberg; J J Dunn; J W Dubendorff
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

5.  Eukaryotic expression vectors for the analysis of mutant proteins.

Authors:  P Matthias; M M Müller; E Schreiber; S Rusconi; W Schaffner
Journal:  Nucleic Acids Res       Date:  1989-08-11       Impact factor: 16.971

6.  Activation of NF-kappa B requires proteolysis of the inhibitor I kappa B-alpha: signal-induced phosphorylation of I kappa B-alpha alone does not release active NF-kappa B.

Authors:  Y C Lin; K Brown; U Siebenlist
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

7.  Complete nucleotide sequence of bacteriophage T7 DNA and the locations of T7 genetic elements.

Authors:  J J Dunn; F W Studier
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

8.  Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B.

Authors:  S Ghosh; D Baltimore
Journal:  Nature       Date:  1990-04-12       Impact factor: 49.962

9.  Cyclin is degraded by the ubiquitin pathway.

Authors:  M Glotzer; A W Murray; M W Kirschner
Journal:  Nature       Date:  1991-01-10       Impact factor: 49.962

10.  I kappa B: a specific inhibitor of the NF-kappa B transcription factor.

Authors:  P A Baeuerle; D Baltimore
Journal:  Science       Date:  1988-10-28       Impact factor: 47.728

View more
  53 in total

1.  Activation of the Drosophila NF-kappaB factor Relish by rapid endoproteolytic cleavage.

Authors:  S Stöven; I Ando; L Kadalayil; Y Engström; D Hultmark
Journal:  EMBO Rep       Date:  2000-10       Impact factor: 8.807

Review 2.  Chaperone rings in protein folding and degradation.

Authors:  A L Horwich; E U Weber-Ban; D Finley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

3.  SCF(beta)(-TrCP) ubiquitin ligase-mediated processing of NF-kappaB p105 requires phosphorylation of its C-terminus by IkappaB kinase.

Authors:  A Orian; H Gonen; B Bercovich; I Fajerman; E Eytan; A Israël; F Mercurio; K Iwai; A L Schwartz; A Ciechanover
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

4.  I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity.

Authors:  S T Whiteside; J C Epinat; N R Rice; A Israël
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

Review 5.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

Review 6.  Ubiquitin signalling in the NF-kappaB pathway.

Authors:  Zhijian J Chen
Journal:  Nat Cell Biol       Date:  2005-08       Impact factor: 28.824

7.  A new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription.

Authors:  Z Li; G J Nabel
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

8.  Slippery substrates impair ATP-dependent protease function by slowing unfolding.

Authors:  Daniel A Kraut
Journal:  J Biol Chem       Date:  2013-10-22       Impact factor: 5.157

9.  Caspase-mediated processing of the Drosophila NF-kappaB factor Relish.

Authors:  Svenja Stoven; Neal Silverman; Anna Junell; Marika Hedengren-Olcott; Deniz Erturk; Ylva Engstrom; Tom Maniatis; Dan Hultmark
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

10.  Origins of immunity: Relish, a compound Rel-like gene in the antibacterial defense of Drosophila.

Authors:  M S Dushay; B Asling; D Hultmark
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.